Le Lézard
Classified in: Health
Subjects: FDA, IMA

PDO Max® Continues to Successfully Earn Medical Device Single Audit Program Certification


SYRACUSE, N.Y., April 5, 2022 /PRNewswire/ -- PDO Max, Inc., a leader in FDA cleared Polydioxanone (PDO) threads-in-cannula medical devices for non-surgical facial tissue repositioning, is proud to announce that their PDO device continues to comply with The Medical Device Single Audit Program ? or MDSAP ?certification.

Being MDSAP certified means that your company has met the quality management standards of multiple, regulatory jurisdictions including those of Australia, Brazil, Canada, Japan, and the United States. The FDA states on its website, "a global approach to auditing and monitoring the manufacturing of medical devices could improve their safety and oversight on an international scale."

PDO Max is also ISO-13485: 2016 certified, which means they have demonstrated their ability to provide medical devices under very rigorous quality expectations. ISO-13485: 2016 evaluates whether a company's Quality Management System is appropriate and effective while emphasizing the safety and efficacy of medical devices.

PDO Max is focused on quality management, safety, and training of its absorbable PDO threads-in-cannula. Just as they took the time to go through the rigorous FDA approval process (K190245), they took the time to participate in a global auditing certification to ensure they meet the highest safety and high-quality device standards on a global scale.

"At PDO Max, we don't cut corners, and we take the time to make sure we are doing everything the right and safe way so that medical practitioners can sleep at night knowing that our FDA cleared medical device that was placed in their patient's skin is safe, reliable, and effective," Giovanna McCarthy, CEO and Founder of PDO Max, states.

Among their safety certifications, the company and manufacturer are fully insured. The PDO threads are designed and manufactured by PDO Max, and every package is properly labeled with our branding, lot numbers, and QR code so that the company and the clinic can track the device being used in the event of a complication.

About: PDO MAX, Inc. is headquartered in Liverpool, NY, and is a female-owned medical device provider for medical aesthetic needs in the U.S. PDO Max is the trusted provider of hundreds of medical practices utilizing its proprietary FDA cleared (K190245) Polydioxanone (PDO) threads- in-cannula. PDO Max offers hands-on individual instructional courses, which cover the application of PDO thread techniques. For more information regarding PDO MAX threads, to place an order, or to schedule a training, please contact PDO MAX at 800-670-0225 or visit https://www.pdomax.com.

Media Contact
Diana Daly
800.670.0225
[email protected]

SOURCE PDO Max


These press releases may also interest you

at 14:57
Product: Gift Chocolate Issue: Food - Allergen - Milk; Food - Allergen - Soy Distribution: Ontario, Quebec See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:55
The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K...

at 11:30
The National Alliance on Mental Illness Greater L.A. County (NAMI GLAC) will celebrate its 20th annual NAMIWalks Greater LA County Mental Health Festival during Mental Health Awareness Month on Saturday, May 4, 2024. This free community wide event at...

at 10:30
Flourishing Foundations Recovery has launched a new outpatient detox center in San Antonio, TX, aiming to help individuals tackle drug and alcohol addiction without pausing their daily lives. The new substance abuse treatment center ensures easy...

at 08:30
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...



News published on and distributed by: